Actinium Pharmaceuticals, Inc. (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced a clinical program comprising of trials studying Actimab-A in ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

Initial results found that among 1060 participants in 30 countries, the pembrolizumab plus CCRT group conferred better PFS at 24 months than the placebo plus CCRT group (68% vs 57%; hazard ratio [HR], ...

The Association of Cancer Care Centers (ACCC), in collaboration with Eli Lilly and Company, is pleased to announce the seven recipients of the "Improving the Precision Oncology Care Pathway" Request ...

Can Your Diet Help Prevent Lung Cancer? Scientists Explore the LinkFor cancers of organs like the liver, the long-term impact of our diet has been ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

M. Michele Blackwood, MD, FACS, highlights an innovative trial delivering 1 week of pre-surgery and 2 weeks of post-surgery ...

Heavy-ion therapy, one of the most advanced radiotherapy techniques, has proven to be more effective than conventional X-rays ...

Cancer isn’t just one disease, but many — each with its own challenges, characteristics, risks and treatments. As we have worked tirelessly to understand this group of diseases, I’ve witnessed a ...

RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...

Researchers at UC San Diego have developed advanced deep learning techniques that could revolutionize treatment planning for breast cancer radiotherapy – making it faster and improving its quality.